Innate Pharma IPHA Income Statement (2017-2025)

NASDAQ IPHA
$2.23 +0.14 (+6.70%)
As of: Aug 21, 2026 · 1:03 PM EDT
Income Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Shares Outstanding (Entity) (Quarter) 54.0059.0064.0067.0079.0079.0079.0080.0080.0080.0080.0080.0081.0081.0087.0090.00
Revenue & cost
Revenue (Quarter) 0.08B0.07B0.01B0.02B50.58B0.04B0.06B0.01B0.01B0.00B
Operating items
Amortization - Intangibles (Quarter) -0.05B-0.00B
Research & Development (Quarter) -0.04B-0.09B-0.03B-0.06B-0.03B-0.05B-0.03B-0.05B-0.03B-0.06B-0.03B-0.06B-0.02B-0.05B
Selling, General & Administrative (Quarter) -0.01B-0.03B-0.02B-0.02B-0.02B-0.03B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B
Restructuring Costs (Quarter) -0.04B
Other Operating Expenses (Quarter) 0.000.04B0.000.00B0.000.00B
Operating Expenses (Quarter) -0.05B-0.12B-0.05B-0.08B-0.05B-0.08B-0.04B-0.08B-0.04B-0.08B-0.04B-0.08B-0.03B-0.07B
Operating Income (Quarter) -0.01B-0.03B-0.05B-0.00B-0.03B-0.03B
EBIT (Quarter) -0.03B-0.01B-0.01B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Non-operating items
Non Operating Income (Quarter) -0.00B-0.00B-0.00B-0.00B
Net income details
EBT (Quarter) -0.02B-0.01B-0.00B-0.03B-0.05B-0.02B0.00B-0.01B-0.03B-0.05B-0.02B-0.06B
Profit After Tax (Quarter) -0.02B-0.01B-0.08B0.06B-0.06B-0.06B0.00B-0.01B0.05B-0.05B0.05B-0.06B
Income from Continuing Operations (Quarter) -0.02B-0.01B-0.00B-0.03B-0.05B-0.02B0.00B-0.01B-0.03B-0.05B-0.02B-0.06B
Consolidated Net Income (Quarter) -0.02B-0.01B-0.08B-0.03B-0.01B-0.00B-0.00B0.00B-0.01B-0.03B-0.05B-0.02B
Income towards Parent Company (Quarter) -0.02B-0.01B-0.08B-0.03B0.12B-0.00B0.06B0.00B-0.01B-0.03B-0.05B-0.02B
Net Income towards Common Stockholders (Quarter) -0.02B-0.01B-0.08B-0.03B0.12B-0.00B0.06B0.00B-0.01B-0.03B-0.05B-0.02B
Additional items
EPS (Basic) (Quarter) -0.34-0.14-0.95-0.361.550.000.690.01-0.10-0.33-0.65-0.28
EPS (Diluted) (Quarter) -0.361.560.000.690.01-0.10-0.33-0.65-0.28
Shares Outstanding (Quarter) 0.05B0.06B0.06B0.07B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.09B0.09B
Shares Outstanding (Diluted) (Quarter) 0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.09B0.09B
EBITDA (Quarter) -0.03B-0.01B-0.01B-0.03B-0.05B-0.02B-0.00B-0.01B-0.03B-0.06B-0.03B-0.06B
Interest Expenses (Quarter) 0.00B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B